Edge Pharma, LLC 2022-02-02 Health serious FDA
Health · FDA · Recall #FDA-D-0448-2022
Vancomycin HCl Oral Solution (PF) 125mg / 2.5mL (50 mg/mL), 2.5 mL per syringe, Single… Recall
Issued February 2, 2022 · Edge Pharma, LLC
In February 2022, Edge Pharma, LLC recalled the Vancomycin HCl Oral Solution (PF) 125mg / 2.5mL (50 mg/mL), 2.5 mL per syringe, Single…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations
What you should do
- 1 Stop using Vancomycin HCl Oral Solution (PF) 125mg / 2.5mL (50 mg/mL), 2.5 mL per syringe, Single… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Edge Pharma, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Edge Pharma, LLC
- Category
- Health
- Recall date
- February 2, 2022
- Units affected
- Not reported
- Sold at
- nationwide
- Recall number
- FDA-D-0448-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Edge Pharma, LLC has 30 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.